Effects of chlorpromazine, thioridazine and haloperidol on adrenergic transmitter mechanisms in man.
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology*; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007498:Iris / Q000378:metabolism; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism; D009661:Nortriptyline / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects*; D013881:Thioridazine / Q000494:pharmacology*; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology
D011941:Receptors, Adrenergic; D014316:Tritium; D009661:Nortriptyline; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine; D009638:Norepinephrine; D014439:Tyramine; D010646:Phentolamine